EFPIA-PhRMA's principles for clinical trial data sharing have been misunderstood
Citation
Doshi, P. (2013). EFPIA-PhRMA's principles for clinical trial data sharing have been misunderstood. BMJ 2013;347:f5164. DOI: https://doi.org/10.1136/bmj.f5164Keyword
clinical trial datadata sharing
research transparency
European Federation of Pharmaceutical Industries and Associations
Pharmaceutical Research and Manufacturers of America
Clinical Trials as Topic
Information Dissemination
Identifier to cite or link to this item
http://hdl.handle.net/10713/6586ae974a485f413a2113503eed53cd6c53
10.1136/bmj.f5164
Scopus Count
Collections
Related articles
- PhRMA's Code on Interactions with Healthcare Professionals.
- Authors: Bieri D
- Issue date: 2010 Oct
- Adaptive designs in clinical drug development: opportunities, challenges, and scope reflections following PhRMA's November 2006 workshop.
- Authors: Krams M, Burman CF, Dragalin V, Gaydos B, Grieve AP, Pinheiro J, Maurer W, Gallo P
- Issue date: 2007
- PhRMA's new chief. Castellani seen as coalition builder, but some skeptical.
- Authors: Rhea S
- Issue date: 2010 Jul 19
- Access to patient-level trial data--a boon to drug developers.
- Authors: Eichler HG, Pétavy F, Pignatti F, Rasi G
- Issue date: 2013 Oct 24
- Europe. Drug watchdog ponders how to open clinical trial data vault.
- Authors: Rabesandratana T
- Issue date: 2013 Mar 22